TrialScientific reports2024

Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade.

Licia Rivoltini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.